Liminatus Pharma, Inc Warrants
Quarterly Financials
| Values in thousands | 2025-03-31 |
|---|---|
Revenue | $0 |
EBITDA | |
Net Income | |
Net Change In Cash | 0 |
Free Cash Flow | 0 |
Cash | |
Basic Shares | 26,014 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -4,809 | -2,709 |
Net Income | -4,984 | -2,928 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -3,345 | -869 |
Cash | 434 | 5,048 |
Basic Shares | 26,714 | 26,714 |
